BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 20600409)

  • 1. Chronotherapy and the molecular clock: Clinical implications in oncology.
    Innominato PF; Lévi FA; Bjarnason GA
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian timing in cancer treatments.
    Lévi F; Okyar A; Dulong S; Innominato PF; Clairambault J
    Annu Rev Pharmacol Toxicol; 2010; 50():377-421. PubMed ID: 20055686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronopharmacological strategies: Intra- and inter-individual variability of molecular clock.
    Ohdo S; Koyanagi S; Matsunaga N
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):885-97. PubMed ID: 20638941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
    Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circadian timing system in clinical oncology.
    Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
    Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronopharmacology and chronotherapy of cancers].
    Lévi F
    Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronotherapeutics: the relevance of timing in cancer therapy.
    Lévi F
    Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
    Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
    Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.
    Ozturk N; Ozturk D; Kavakli IH; Okyar A
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotherapy of cancer: biological basis and clinical application.
    Lévi F
    Pathol Biol (Paris); 1994 Apr; 42(4):338-41. PubMed ID: 7808787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
    Lévi F
    Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics.
    Lévi F; Okyar A
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1535-41. PubMed ID: 22097903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrono-drug-delivery focused on biological clock: intra- and inter-individual variability of molecular clock.
    Ohdo S
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):857-8. PubMed ID: 20553776
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer chronotherapy: a drug delivery challenge.
    Hrushesky WJ
    Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotherapeutic strategy: Rhythm monitoring, manipulation and disruption.
    Ohdo S
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):859-75. PubMed ID: 20188774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological perspectives on circadian cancer therapy.
    Wood PA; Hrushesky WJ
    J Infus Chemother; 1995; 5(4):182-90. PubMed ID: 8934723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma: Chronopharmacotherapy and the molecular clock.
    Burioka N; Fukuoka Y; Koyanagi S; Miyata M; Takata M; Chikumi H; Takane H; Watanabe M; Endo M; Sako T; Suyama H; Ohdo S; Shimizu E
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):946-55. PubMed ID: 20359514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily coordination of cancer growth and circadian clock gene expression.
    You S; Wood PA; Xiong Y; Kobayashi M; Du-Quiton J; Hrushesky WJ
    Breast Cancer Res Treat; 2005 May; 91(1):47-60. PubMed ID: 15868431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical cancer chronotherapy trials: a review.
    Bjarnason GA
    J Infus Chemother; 1995; 5(1):31-7. PubMed ID: 7634175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms.
    Hrushesky WJ; Grutsch J; Wood P; Yang X; Oh EY; Ansell C; Kidder S; Ferrans C; Quiton DF; Reynolds J; Du-Quiton J; Levin R; Lis C; Braun D
    Integr Cancer Ther; 2009 Dec; 8(4):387-97. PubMed ID: 19926611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.